Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 4Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Classical hematology 2

Conditions

Multiple Myeloma 38Lymphoma, Non-Hodgkin 14Hodgkin Disease 13Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Myelodysplastic Syndromes 11Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Neoplasms, Plasma Cell 10Leukemia, Myeloid, Acute 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Hematologic Neoplasms 6Primary Myelofibrosis 4Recurrence 3Myeloproliferative Disorders 3Lymphoma, Follicular 3Leukemia, Plasma Cell 3Leukemia, Myelomonocytic, Chronic 3Graft vs Host Disease 3Anemia, Aplastic 3Polycythemia Vera 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Hematologic Diseases 2Wilms Tumor 1Thrombocytopenia 1Thrombocythemia, Essential 1Testicular Neoplasms 1Smoldering Multiple Myeloma 1

Interventions

fludarabine phosphate 20Cyclophosphamide 18Peripheral Blood Stem Cell Transplantation 16Tacrolimus 13Mycophenolic Acid 12Whole-Body Irradiation 11Busulfan 11Methotrexate 8Antilymphocyte Serum 8Filgrastim 6Cyclosporine 6fludarabine 4Radiotherapy 4Melphalan 4Etoposide 4Methylprednisolone 3liposomal amphotericin B 2Stem Cell Transplantation 2Ondansetron 2Morphine 2Leucovorin 2Interferon-alpha 2Fentanyl 2Early Intervention, Educational 2Cord Blood Stem Cell Transplantation 2Caspofungin 2Carboplatin 2tipifarnib 1thymoglobulin 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Polycythemia Vera × Stem Cell Transplantation × Plasma cell × Clear all
NCT01760655 2025-10-30

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Thomas Jefferson University

Phase 2 Completed
62 enrolled 15 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Leukemia, Myeloid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT05031897 2025-10-30

Two Step Haplo With Radiation Conditioning

Thomas Jefferson University

Phase 2 Recruiting
63 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡